Search Resources (English): Clinical practice guidelines

Recommends that routine screening for depression in asymptomatic individuals be excluded from periodic health assessments based on fair evidence that such screening by questionnaire did not improve detection rate or management. Also recommends physicians should be sensitive to the possibility of depression in their patients, particularly those at higher risk. (See Details)

Discusses warnings regarding the drug, Diane-35, and the drug's risk of venous thromboembolism. States that Diane-35 should be reserved for temporary use in women with serious acne and should not be used solely as an oral contraceptive. (See Details)

Discusses the Society of Obstetricians and Gynaecologists' Intimate Partner Violence Consensus Statement. (See Details)

Reviews the evidence for and against HPV screening in asymptomatic women and concludes that screening should not be done since therapy is ineffective and potentially harmful. (See Details)

Provides a protocol for medical practitioners about using medical abortion medications mifepristine and misoprostol in a health clinic setting. (See Details)

Provides clinical recommendations for medical abortion with mifepristone and misoprostol. (See Details)

Provides a manual that supports early recognition and response to preterm labour in order to provide timely and appropriate levels of care. Includes clinical practice guidelines. (See Details)

Appears as part of a series of occasional articles on common problems in primary care from the British Medical Journal. Provides clinical direction for health providers treating women with recurrent urinary tract infections. (See Details)

Reviews the evidence for screening for human papillomavirus (HPV) infection in asymptomatic women. (See Details)

Presents clinical guidelines for the use of misoprostol for a medical abortion. (See Details)